| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 18.782 | 23.215 | 21.055 | 29.245 | 53.017 | 68.828 | 77.991 |
| Total Income - EUR | - | - | - | 18.782 | 23.218 | 21.055 | 29.245 | 53.017 | 68.828 | 77.991 |
| Total Expenses - EUR | - | - | - | 11.754 | 16.673 | 21.452 | 22.520 | 30.296 | 46.546 | 61.783 |
| Gross Profit/Loss - EUR | - | - | - | 7.029 | 6.545 | -396 | 6.725 | 22.721 | 22.282 | 16.208 |
| Net Profit/Loss - EUR | - | - | - | 6.465 | 5.848 | -1.028 | 5.848 | 21.608 | 21.593 | 13.574 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Miocky - Med - Prod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 2.613 | 32.715 | 25.051 | 17.609 | 22.426 | 14.961 | 16.988 |
| Current Assets | - | - | - | 4.002 | 5.868 | 9.404 | 19.685 | 32.719 | 25.221 | 19.516 |
| Inventories | - | - | - | 502 | 418 | 646 | 632 | 634 | 2.080 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 6.717 | 728 |
| Cash | - | - | - | 3.500 | 5.450 | 8.758 | 19.053 | 32.085 | 16.424 | 18.789 |
| Shareholders Funds | - | - | - | 6.508 | 12.227 | 10.971 | 16.602 | 38.261 | 21.642 | 35.095 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 106 | 26.356 | 23.484 | 20.691 | 16.883 | 18.540 | 1.785 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Miocky - Med - Prod S.r.l.